These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 39192233)

  • 1. Purification and characterization of soluble recombinant Crimean-Congo hemorrhagic fever virus glycoprotein Gc expressed in mammalian 293F cells.
    Makoah NA; Litabe MM; Simo FBN; Maboho KK; Burt FJ
    BMC Biotechnol; 2024 Aug; 24(1):59. PubMed ID: 39192233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel double-antigen sandwich ELISA for the species-independent detection of Crimean-Congo hemorrhagic fever virus-specific antibodies.
    Sas MA; Comtet L; Donnet F; Mertens M; Vatansever Z; Tordo N; Pourquier P; Groschup MH
    Antiviral Res; 2018 Mar; 151():24-26. PubMed ID: 29330092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fine mapping epitope on glycoprotein Gc from Crimean-Congo hemorrhagic fever virus.
    Zhang J; Simayi A; Wang M; Moming A; Xu W; Wang C; Li Y; Ding J; Deng F; Zhang Y; Sun S
    Comp Immunol Microbiol Infect Dis; 2019 Dec; 67():101371. PubMed ID: 31627038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleoside-Modified mRNA Vaccines Protect IFNAR
    Appelberg S; John L; Pardi N; Végvári Á; Bereczky S; Ahlén G; Monteil V; Abdurahman S; Mikaeloff F; Beattie M; Tam Y; Sällberg M; Neogi U; Weissman D; Mirazimi A
    J Virol; 2022 Feb; 96(3):e0156821. PubMed ID: 34817199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of two serological methods for detecting IgG and neutralizing antibodies against Crimean-Congo hemorrhagic fever virus glycoprotein.
    Wang Q; Wang S; Shi Z; Li Z; Zhao Y; Feng N; Wang T; Yan F; Xia X
    Front Cell Infect Microbiol; 2024; 14():1341332. PubMed ID: 38746783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice.
    Hinkula J; Devignot S; Åkerström S; Karlberg H; Wattrang E; Bereczky S; Mousavi-Jazi M; Risinger C; Lindegren G; Vernersson C; Paweska J; van Vuren PJ; Blixt O; Brun A; Weber F; Mirazimi A
    J Virol; 2017 May; 91(10):. PubMed ID: 28250124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitive and specific detection of Crimean-Congo Hemorrhagic Fever Virus (CCHFV)-Specific IgM and IgG antibodies in human sera using recombinant CCHFV nucleoprotein as antigen in μ-capture and IgG immune complex (IC) ELISA tests.
    Emmerich P; Mika A; von Possel R; Rackow A; Liu Y; Schmitz H; Günther S; Sherifi K; Halili B; Jakupi X; Berisha L; Ahmeti S; Deschermeier C
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006366. PubMed ID: 29579040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A competitive ELISA for species-independent detection of Crimean-Congo hemorrhagic fever virus specific antibodies.
    Schuster I; Mertens M; Köllner B; Korytář T; Keller M; Hammerschmidt B; Müller T; Tordo N; Marianneau P; Mroz C; Rissmann M; Stroh E; Dähnert L; Hammerschmidt F; Ulrich RG; Groschup MH
    Antiviral Res; 2016 Oct; 134():161-166. PubMed ID: 27623345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of broadly neutralizing monoclonal antibodies against Crimean-Congo hemorrhagic fever virus.
    Zivcec M; Guerrero LIW; Albariño CG; Bergeron É; Nichol ST; Spiropoulou CF
    Antiviral Res; 2017 Oct; 146():112-120. PubMed ID: 28842265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of double antibody sandwich ELISA as potential diagnostic tool for rapid detection of Crimean-Congo hemorrhagic fever virus.
    Shrivastava N; Kumar JS; Yadav P; Shete AM; Jain R; Shrivastava A; Dash PK
    Sci Rep; 2021 Jul; 11(1):14699. PubMed ID: 34282163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of diagnostic performances of ten different immunoassays detecting anti-CCHFV IgM and IgG antibodies from acute to subsided phases of Crimean-Congo hemorrhagic fever.
    Emmerich P; von Possel R; Deschermeier C; Ahmeti S; Berisha L; Halili B; Jakupi X; Sherifi K; Messing C; Borchardt-Lohölter V
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009280. PubMed ID: 33720942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant nucleoprotein-based enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Crimean-Congo hemorrhagic fever virus.
    Saijo M; Qing T; Niikura M; Maeda A; Ikegami T; Prehaud C; Kurane I; Morikawa S
    J Clin Microbiol; 2002 May; 40(5):1587-91. PubMed ID: 11980926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and Characterization of Crimean-Congo Hemorrhagic Fever Virus GP38.
    Mishra AK; Moyer CL; Abelson DM; Deer DJ; El Omari K; Duman R; Lobel L; Lutwama JJ; Dye JM; Wagner A; Chandran K; Cross RW; Geisbert TW; Zeitlin L; Bornholdt ZA; McLellan JS
    J Virol; 2020 Mar; 94(8):. PubMed ID: 31996434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Nucleoprotein-Based Enzyme-Linked Immunosorbent Assay for Serodiagnosis of Acute Crimean-Congo Hemorrhagic Fever Virus Infections in a Turkish Population.
    Cosgun Y; Aydemir A; Hedef H; Öz Kamiloglu A; Klemens O; Lattwein E; Klemens JM; Saschenbrecker S; Steinhagen K; Korukluoglu G
    Vector Borne Zoonotic Dis; 2023 Jan; 23(1):44-53. PubMed ID: 36576857
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of a novel recombinant ELISA for the detection of Crimean-Congo hemorrhagic fever virus IgG antibodies.
    Gülce-İz S; Elaldı N; Can H; Şahar EA; Karakavuk M; Gül A; Kumoğlu GÖ; Döşkaya AD; Gürüz AY; Özdarendeli A; Felgner PL; Davies H; Döşkaya M
    Sci Rep; 2021 Mar; 11(1):5936. PubMed ID: 33723328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crimean-Congo hemorrhagic fever virus in livestock ticks and animal handler seroprevalence at an abattoir in Ghana.
    Akuffo R; Brandful JA; Zayed A; Adjei A; Watany N; Fahmy NT; Hughes R; Doman B; Voegborlo SV; Aziati D; Pratt D; Awuni JA; Adams N; Dueger E
    BMC Infect Dis; 2016 Jul; 16():324. PubMed ID: 27392037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of IgG antibody against Crimean-Congo haemorrhagic fever virus using ELISA with recombinant nucleoprotein antigens from genetically diverse strains.
    Rangunwala A; Samudzi RR; Burt FJ
    Epidemiol Infect; 2014 Oct; 142(10):2147-54. PubMed ID: 24330947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudo-plaque reduction neutralization test (PPRNT) for the measurement of neutralizing antibodies to Crimean-Congo hemorrhagic fever virus.
    Canakoglu N; Berber E; Ertek M; Yoruk MD; Tonbak S; Bolat Y; Aktas M; Kalkan A; Ozdarendeli A
    Virol J; 2013 Jan; 10():6. PubMed ID: 23282186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plant-produced Crimean-Congo haemorrhagic fever virus nucleoprotein for use in indirect ELISA.
    Atkinson R; Burt F; Rybicki EP; Meyers AE
    J Virol Methods; 2016 Oct; 236():170-177. PubMed ID: 27474493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological and molecular study of Crimean-Congo Hemorrhagic Fever Virus in cattle from selected districts in Uganda.
    Balinandi S; von Brömssen C; Tumusiime A; Kyondo J; Kwon H; Monteil VM; Mirazimi A; Lutwama J; Mugisha L; Malmberg M
    J Virol Methods; 2021 Apr; 290():114075. PubMed ID: 33515661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.